Canadian biotech firms' creative capacity: on the role of absorptive capacity, relational capital, learning, and firm characteristics
by Namatie Traore
International Journal of Biotechnology (IJBT), Vol. 6, No. 1, 2004

Abstract: The research reported in this paper focuses on factors that enhance Canadian Biotech firms' creative capacity. Using the number of products and processes at all stages of development as an indicator of creative capacity, results show that absorptive capacity, relational capital, learning, expansion into international markets, and firm characteristics are all key determinants of creative capacity. However, not all these factors are equally important at all stages of product development. For example, results show that at the R&D stage, success drivers are firm absorptive capacity and firm characteristics. But issues related to product commercialisation have no bearing on creative capacity at that stage. Expansion into international markets and experience in biotechnology are the greatest firm creative capacity assets at the production/commercialisation stage.

Online publication date: Wed, 26-May-2004

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com